TIDMTEK
Tekcapital plc
11 March 2021
11 March 2021
Tekcapital Plc
("Tekcapital", the "Company" or "the Group")
Portfolio Company Update: Salarius, Ltd. ("Salarius")
Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual
property investment group focused on creating valuable products
from investing in university technology, is very pleased to
announce that portfolio company Salarius Ltd. has appointed board
member Eduardo Souchon as V.P. of Business Development and Jay
Shah, M.D. as a medical Advisor to its science advisory board.
Eduardo Souchon is a business and brand/marketing executive with
a 20-year track record in taking businesses focused on snacks
(Pringles(R)), health related products and office supplies to
breakthrough financial and market success in the CPG and retail
industry. Eduardo has significant end-to-end experience in brand
building, innovation, and strategy with Procter and Gamble and
Office Depot.
"As a director of Salarius, I am passionate about the mission of
Salarius, and its potential to improve people's lives with
healthier, low-sodium foods. Victor has assembled a terrific team
and I am very glad to join it in an operating role, focused on B2B
sales. The potential of the business is significant," said Eduardo
Souchon.
Dr. Shah comes to the team with more than a decade of experience
in cardiovascular medicine, and currently serves as a senior
associate consultant with the Mayo Clinic and assistant professor
at Mayo Clinic Alix School of Medicine.
"As an investor and advisor, I look for ideas and companies that
have the potential to impact our world in a meaningful way," Dr.
Shah said. "MicroSalt is poised to be part of a larger solution to
reducing our consumption of sodium and the negative health
consequences associated with our excessive intake of salt."
MicroSalt aims to revolutionize the food industry with a
patented sodium nanoparticle engineered to deliver the full flavor
experience of salt with half the sodium. MicroSalt's powdered salt
particles are approximately 100 times smaller than regular table
salt, allowing them to be rapidly dissolved. MicroSalt(R) is
all-natural, non-GMO, and Kosher.
"We're excited to add Eduardo Souchon and Dr. Shah to our team,"
said Victor Hugo Manzanilla, CEO of MicroSalt. "Souchon's
experience managing one of the largest snack food brands in the
world and Dr. Shah's knowledge as a cardiologist, together should
enhance the future growth and development of MicroSalt."
About Salarius Ltd.
Salarius, is the developer and manufacturer of a proprietary
low-sodium salt called MicroSalt(R). We are passionate about
improving peoples' lives with better-for-you snacks by taking the
lead in the industry by providing the best low-sodium salt
solution, based on the mechanical transformation of the salt
particle itself. This solution is the only one that delivers real
salt flavor because it is salt. Our new patented technology
produces salt crystals that are approximately one hundred times
smaller than typical table salt, delivering a powerful saltiness as
the micro-grains dissolve in the mouth, with approximately 50% less
sodium consumption.
Additionally, the ultra-small particle size enhances product
adhesion, which reduces waste and provides improved flavor
consistency. MicroSalt(R) and SaltMe(R) are registered trademarks
of MicroSalt Inc.
To learn more please visit https://Salarius.co .
Tekcapital owns 97.2% of the share capital of Salarius Ltd.
Microsalt Inc. is an 87.1% owned U.S. subsidiary of Salarius
Ltd.
About Tekcapital plc
Tekcapital creates value from investing in new,
university-developed discoveries that can enhance people's lives
and provides a range of technology transfer services to help
organisations evaluate and commercialise new technologies.
Tekcapital is quoted on the AIM market of the London Stock Exchange
(AIM: symbol TEK) and is headquartered in the UK. For more
information, please visit www.tekcapital.com .
LEI: 213800GOJTOV19FIFZ85
For further information, please contact:
Tekcapital Plc Via Flagstaff IR
Clifford M. Gross, Ph.D.
SP Angel Corporate Finance LLP (Nominated
Adviser and Joint Broker) +44 (0) 20 3470 0470
Richard Morrison / Charlie Bouverat (Corporate
Finance)
Abigail Wayne / Rob Rees (Corporate Broking)
Flagstaff Strategic and Investor Communications +44 (0)207 129
1474
Tim Thompson/Andrea Seymour/Fergus Mellon
This press release is for informational purposes only. The
information herein does not constitute investment advice nor an
offer to invest and may contain statements related to our future
business and financial performance and future events or
developments involving Salarius that may constitute forward-looking
statements. These statements may be identified by words such as
"expect," "look forward to," "anticipate" "intend," "plan,"
"believe," "seek," "estimate," "will," "project" or words of
similar meaning. We may also make forward-looking statements in
other reports, in presentations, in material delivered to
customers, stakeholders and in press releases. In addition, our
representatives may from time to time make oral forward-looking
statements. Such statements may be based on the current
expectations and certain assumptions of Salarius' and/or
Tekcapital's management. Please note that these are subject to a
number of risks, uncertainties and factors, including, but not
limited to those described in various disclosures. Should one or
more of these risks or uncertainties materialize, or should
underlying expectations not occur or assumptions prove incorrect,
actual results, performance or achievements of Salarius or
Tekcapital may vary materially from those described explicitly or
implicitly in the relevant forward-looking statement. Neither
Salarius nor Tekcapital intends, nor assumes any obligation, to
update or revise these forward-looking statements in light of
developments which differ from those anticipated.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAADEFFSFEAA
(END) Dow Jones Newswires
March 11, 2021 02:00 ET (07:00 GMT)
Grafico Azioni Tekcapital (LSE:TEK)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Tekcapital (LSE:TEK)
Storico
Da Lug 2023 a Lug 2024